{"id":109690,"date":"2023-09-12T11:38:55","date_gmt":"2023-09-12T06:08:55","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=109690"},"modified":"2023-09-12T12:48:26","modified_gmt":"2023-09-12T07:18:26","slug":"pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/","title":{"rendered":"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2463985915\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1009757832\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalization of Rs 52,000 crores, the stocks of Lupin Limited, a pharma company, started their trading session on Tuesday at Rs 1,135 and currently trade at Rs 1,142.50.&nbsp;<\/p><p>The company\u2019s scrip witnessed an intra-day high, also marked as the company\u2019s 52-week high price, of Rs 1,174.25 indicating a gain of around 4 percent as compared to the previous close of Rs 1,127.90 apiece.&nbsp;<\/p><p>The bullish sentiments in the stock were observed after the company informed that it plans to enter into a Business Transfer Agreement with \u201cLupin Manufacturing Solutions Limited\u201d (LMSL), a wholly owned subsidiary of Lupin, to carve out two manufacturing sites pertaining to the API, i.e., Active Pharmaceutical Ingredients segment at Visakhapatnam &amp; Dabhasa.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-964714187\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The consideration expected to be received from the above-mentioned transaction is around 7,500-8,500 million rupees, and, is estimated to be executed by the end of December 2023.&nbsp;<\/p><p>During the recent quarters, the company\u2019s financial performance has been decent with the operating revenues going up from Rs 4,430.08 crores during Q4FY22-23 to Rs 4,814.06 crores during Q1FY23-24, and, the after-tax profits too, in congruence, went up from Rs 242.39 crores to Rs 453.33 crores.&nbsp;<\/p><p>According to the shareholding pattern data available for the June 2023 quarter, the company\u2019s Promoters hold a 47.07 percent stake, and the Foreign Institutional Investors (FIIs) hold a 13.93 percent stake in the company.&nbsp;<\/p><p>Lupin Limited is a generic drug manufacturing company that is engaged in the business of developing as well as delivering a wide range of formulations across the globe. The majority of the company\u2019s revenue is been generated by sales in the United States which is then followed by sales in the Indian regions.&nbsp;<\/p><p><strong>Written by Amit Madnani\u00a0<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3827407988\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.&nbsp; With a market capitalization of Rs 52,000 crores, the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":49884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[],"class_list":["post-109690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary\" \/>\n<meta property=\"og:description\" content=\"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-12T06:08:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-12T07:18:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/\",\"name\":\"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"datePublished\":\"2023-09-12T06:08:55+00:00\",\"dateModified\":\"2023-09-12T07:18:26+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary - Trade Brains Features","description":"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary","og_description":"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-09-12T06:08:55+00:00","article_modified_time":"2023-09-12T07:18:26+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/","name":"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","datePublished":"2023-09-12T06:08:55+00:00","dateModified":"2023-09-12T07:18:26+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this large-cap Pharma stock jumped 4 percent in Tuesday\u2019s trading session after the company plans to carve out its a couple of manufacturing sites pertaining to its \u2018API\u2019 segment. In the last six months, the stocks of this company have gained nearly 75 percent.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-enters-in-a-business-transfer-agreement-with-subsidiary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 4% after company enters in a Business Transfer Agreement with subsidiary"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=109690"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109690\/revisions"}],"predecessor-version":[{"id":109691,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109690\/revisions\/109691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/49884"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=109690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=109690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=109690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}